Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07IGC
|
|||
| Former ID |
DNCL001933
|
|||
| Drug Name |
DSP-8658
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9] | Phase 1 | [1] | |
| Type-2 diabetes [ICD-11: 5A11] | Phase 1 | [1] | ||
| Company |
Sunovion Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01042106) Safety, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Patients With Type 2 Diabetes Mellitus and Healthy Adults. U.S. National Institutes of Health. | |||
| REF 2 | Effects of DSP-8658, a Novel Selective Peroxisome Proliferator-activated Receptors a/gamma Modulator, on Adipogenesis and Glucose Metabolism in Diabetic Obese Mice. Exp Clin Endocrinol Diabetes. 2015Sep;123(8):492-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.